共 48 条
- [21] Thermodynamic Properties of Propane. III. A Reference Equation of State for Temperatures from the Melting Line to 650 K and Pressures up to 1000 MPaJOURNAL OF CHEMICAL AND ENGINEERING DATA, 2009, 54 (12) : 3141 - 3180Lemmon, Eric W.McLinden, Mark O.Wagner, Wolfgang
- [22] First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 TrialJOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17) : 2012 - 2020Janjigian, Yelena Y.Ajani, Jaffer A.Moehler, MarkusShen, LinGarrido, MarceloGallardo, CarlosWyrwicz, LucjanYamaguchi, KenseiCleary, James M.Elimova, ElenaKaramouzis, MichalisBruges, RicardoSkoczylas, TomaszBragagnoli, ArinildaLiu, TianshiTehfe, MustaphaZander, ThomasKowalyszyn, RubenPazo-Cid, RobertoSchenker, MichaelFeeny, KynanWang, RuiLei, MingChen, ClaraNathani, RaheelShitara, Kohei
- [23] COST UTILITY ANALYSIS OF 90Y-IBRITUMOMAB TIUXETAN FOLLOWING FIRST-LINE CHEMOTHERAPY COMPARED TO NO FOLLOW-UP IN PATIENTS WITH STAGE III OR IV FOLLICULAR LYMPHOMA IN SPAINVALUE IN HEALTH, 2009, 12 (07) : A279 - A279Eggington, S. G.Pinol, C.Musi, E.Valderrama, A.
- [24] High resolution specific heat experiments on the melting line of the vortex glass in YBa2Cu3Ox: Observation of second-order transitions up to 14 teslas.PHYSICA C, 1997, 282 : 1401 - 1402Roulin, MJunod, AWalker, EErb, A
- [25] Temperature, pressure, and perturber dependencies of line-mixing effects in CO2 infrared spectra.: III.: Second order rotational angular momentum relaxation and Coriolis effects in Π←Σ bandsJOURNAL OF CHEMICAL PHYSICS, 1999, 110 (16) : 7733 - 7744Hartmann, JMRodrigues, RNguyen-Van-ThanhBrodbeck, CBoulet, CLe Doucen, RLacome, NBonamy, L
- [26] Temperature, pressure, and perturber dependencies of line-mixing effects in CO2 infrared spectra. III. Second order rotational angular momentum relaxation and Coriolis effects in Π<-Σ bandsJournal of Chemical Physics, 1999, 110 (16):Hartmann, J.-M.Rodrigues, R.Nguyen-Van-ThanhBrodbeck, C.Boulet, C.Le Doucen, R.Lacome, N.Bonamy, L.
- [27] Mabthera (Rituximab) plus CVP chemotherapy for first-line treatment of stage III/IV follicular non-Hodgkin's lymphoma (NHL): Confirmed efficacy with longer follow-up.BLOOD, 2005, 106 (11) : 106A - 106ASolal-Celigny, PImrie, KBelch, ARobinson, KSCunningham, DRueda, ACatalano, JOffner, FWalewski, JRaposo, JSmith, PMarcus, R
- [28] Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trialESMO OPEN, 2020, 5 (06)Albiges, LaurenceTannir, Nizar M.Burotto, MauricioMcDermott, DavidPlimack, Elizabeth R.Barthelemy, PhilippePorta, CamilloPowles, ThomasDonskov, FredeGeorge, SabyKollmannsberger, Christian K.Gurney, HowardGrimm, Marc-OliverTomita, YoshihikoCastellano, DanielRini, Brian, IChoueiri, Toni K.Saggi, Shruti ShallyMcHenry, M. BrentMotzer, Robert J.
- [29] Updated overall survival (OS) from extended follow up in ARCHER 1050: A randomized phase III study comparing dacomitinib with gefitinib as first-line therapy for patients (pts) with EGFR mutationsANNALS OF ONCOLOGY, 2019, 30Mok, T. S. K.Cheng, Y.Zhou, X.Lee, K. H.Nakagawa, K.Niho, S.Linke, R.Rosell, R.Corral, J.Migliorino, M. R.Pluzanski, A.Noonan, K.Tang, Y.Wilner, K. D.Wu, Y-L.
- [30] Effect of subsequent therapies including checkpoint inhibitors on overall survival in a phase III randomized trial of tebentafusp in first-line metastatic uveal melanoma: Long-term follow-upANNALS OF ONCOLOGY, 2023, 34 : S678 - S678Orloff, M.Watkins, C.Carvajal, R. D.Shoushtari, A. N.Sacco, J. J.Schlaak, M.Gama, J.Butler, M. O.